Takashi Higashi

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Although combination therapy with the oral fluoropyrimidine anticancer drug S-1 and the anticonvulsant phenytoin (PHT) is known to increase blood levels of PHT and the risk of intoxication, reports on long-term monitoring of blood levels of PHT during combined S-1 and PHT treatment and a thorough understanding of their interaction are lacking. This report(More)
  • 1